Miraculins Executes Term Sheet to Acquire the SCOUT DS® Non-Invasive Diabetes Screening Technology

News   Apr 15, 2013

 
Miraculins Executes Term Sheet to Acquire the SCOUT DS® Non-Invasive Diabetes Screening Technology
 
 
 

RELATED ARTICLES

Progressive Kidney Disease: New Compound Restores Kidney Function

News

A team led by researchers describe a new approach to prevent death in these essential kidney cells. Studying multiple animal models of kidney disease, the team discovered a compound that can impede loss of the filtration cells and restore kidney function.

READ MORE

3D Mini Brains Accelerate Drug Screening and Brain Function Research

News

Houston Methodist neuroscientist Robert Krencik, Ph.D., and his team have developed a new system to reduce the time it takes to grow these brain models, which will give them the ability to screen drugs and study what’s behind disease-causing mutations more quickly.

READ MORE

Blood Test Could Predict Skin Cancer's Return

News

Cancer Research UK scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE